Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
Completely revised and updated for 2023, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens-both on- and off-label-for the treatment of all the major cancers. Key Features: * Includes new agents and new supplemental indications that have all been approved by the FDA within the past year * Updated new indications for previously approved agents * Indications, drug doses and schedules, toxicities, and special considerations for each agent expanded and revised * A specific chapter focused on antiemetic treatment regimens for both acute and delayed nausea/vomiting * Diagrams of drug structures and pathways for many of the agents * A comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages * Covers toxicity and drug-drug interactions * A section on chemotherapy regimens for all major cancers * Provides an overview of the basic principles of cancer drug therapy
"
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Completely revised and updated for 2023, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens-both on- and off-label-for the treatment of all the major cancers. Key Features: * Includes new agents and new supplemental indications that have all been approved by the FDA within the past year * Updated new indications for previously approved agents * Indications, drug doses and schedules, toxicities, and special considerations for each agent expanded and revised * A specific chapter focused on antiemetic treatment regimens for both acute and delayed nausea/vomiting * Diagrams of drug structures and pathways for many of the agents * A comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages * Covers toxicity and drug-drug interactions * A section on chemotherapy regimens for all major cancers * Provides an overview of the basic principles of cancer drug therapy
"